Receptor tyrosine kinases and downstream pathways as druggable targets for cancer treatment: the current arsenal of inhibitors.
about
Receptor tyrosine kinases and downstream pathways as druggable targets for cancer treatment: the current arsenal of inhibitors.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Receptor tyrosine kinases and ...... current arsenal of inhibitors.
@en
Receptor tyrosine kinases and ...... current arsenal of inhibitors.
@nl
type
label
Receptor tyrosine kinases and ...... current arsenal of inhibitors.
@en
Receptor tyrosine kinases and ...... current arsenal of inhibitors.
@nl
prefLabel
Receptor tyrosine kinases and ...... current arsenal of inhibitors.
@en
Receptor tyrosine kinases and ...... current arsenal of inhibitors.
@nl
P2093
P2860
P921
P1433
P1476
Receptor tyrosine kinases and ...... current arsenal of inhibitors.
@en
P2093
Andrei Ronaldo Oliveira Silva Escartin Salas
Fabiana Henriques Machado de Melo
Wagner Ricardo Montor
P2860
P2888
P356
10.1186/S12943-018-0792-2
P5008
P577
2018-02-19T00:00:00Z
P6179
1101066793